Tech Square Trading LP bought a new position in McKesson Co. (NYSE:MCK) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,900 shares of the company’s stock, valued at approximately $339,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Proficio Capital Partners LLC increased its stake in McKesson by 161.2% in the 4th quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock worth $25,000 after acquiring an additional 137 shares during the last quarter. Bedel Financial Consulting Inc. boosted its holdings in shares of McKesson by 165.2% in the 4th quarter. Bedel Financial Consulting Inc. now owns 236 shares of the company’s stock worth $26,000 after purchasing an additional 147 shares in the last quarter. Smart Portfolios LLC purchased a new position in shares of McKesson in the 1st quarter worth about $35,000. Investors Research Corp purchased a new position in shares of McKesson in the 1st quarter worth about $36,000. Finally, Dubuque Bank & Trust Co. boosted its holdings in shares of McKesson by 106.7% in the 1st quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock worth $40,000 after purchasing an additional 176 shares in the last quarter. Institutional investors and hedge funds own 87.35% of the company’s stock.
A number of equities analysts have recently issued reports on the company. Zacks Investment Research upgraded McKesson from a “sell” rating to a “hold” rating in a report on Wednesday, April 10th. ValuEngine upgraded McKesson from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 8th. Wolfe Research assumed coverage on McKesson in a report on Tuesday, April 2nd. They issued an “outperform” rating for the company. Finally, Barclays reiterated a “hold” rating and issued a $130.00 price objective on shares of McKesson in a report on Friday, February 1st. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $134.90.
MCK stock traded up $0.83 during trading on Monday, hitting $129.92. 1,283,761 shares of the company traded hands, compared to its average volume of 1,621,442. The stock has a market capitalization of $24.68 billion, a PE ratio of 9.57, a P/E/G ratio of 1.31 and a beta of 1.23. McKesson Co. has a 1 year low of $106.11 and a 1 year high of $151.24. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.02 and a quick ratio of 0.58.
McKesson (NYSE:MCK) last issued its earnings results on Wednesday, May 8th. The company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.66 by $0.03. The company had revenue of $52.43 billion during the quarter, compared to analysts’ expectations of $53.14 billion. McKesson had a return on equity of 29.02% and a net margin of 0.02%. McKesson’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the business posted $3.49 EPS. Analysts anticipate that McKesson Co. will post 14.14 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 1.20%. The ex-dividend date is Friday, May 31st. McKesson’s dividend payout ratio is presently 11.50%.
WARNING: This report was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/4354214/tech-square-trading-lp-buys-shares-of-2900-mckesson-co-mck.html.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Recommended Story: How are institutional investors different from individual investors?
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.